Press Releases

 
Press Releases
  Date Title and Summary View
Nov 15, 2007
FREMONT, Calif.--(BUSINESS WIRE)--Zosano Pharma, Inc., an emerging specialty pharmaceutical company focused on developing better pharmaceutical products using innovative drug delivery, has announced the receipt of the second half of its initial venture funding of $45 million, for a total investment of $90 million. Four venture capital firms, New...
Sep 27, 2007
FREMONT, Calif.--(BUSINESS WIRE)--Sept. 27, 2007--The Macroflux Corporation announced today that it has changed the name of the company to Zosano Pharma, Inc. "Our name change reflects the positive evolutionary steps the company is taking to advance our innovative transdermal microprojection delivery system technology," said M. Cory Zwerl...
May 31, 2007
Macroflux, an emerging specialty pharmaceutical company focused on the development of proprietary products, has named M. Cory Zwerling President and CEO of the company. “This is an exciting opportunity to lead Macroflux with a strong team, innovative product opportunities and high caliber Board,” said Mr. Zwerling. “The ...
Oct 10, 2006
Originally a group within ALZA Corporation, The Macroflux Corporation spin-out is being led byNomura Phase4 Ventures, a specialist investor in healthcare. The syndicate includes significant investments from New Enterprise Associates (NEA) and funds managed by HBM Partners. The$75M financing will enable the company to progress several product opp...
Page: FirstPrevious ...
10
= add release to Briefcase